Business
: French vaccine maker Valneva launches Phase 3 trial of its COVID-19 shot after snubbing EU
Valneva’s Phase 3 trial will compare the immune response generated by its vaccine with that of the vaccine developed jointly by AstraZeneca and the University of Oxford